Mortality due to ventilator-associated pneumonia or colonization with Pseudomonas or Acinetobacter species: assessment by quantitative culture of samples obtained by a protected specimen brush
- PMID:8879777
- DOI: 10.1093/clinids/23.3.538
Mortality due to ventilator-associated pneumonia or colonization with Pseudomonas or Acinetobacter species: assessment by quantitative culture of samples obtained by a protected specimen brush
Abstract
Ventilator-associated pneumonia (VAP) due to multiresistant pathogens is associated with a high death rate. We analyzed the relationship between VAP due to Pseudomonas or Acinetobacter species and death by comparing the outcomes for patients colonized with these pathogens (bacterial counts of < 10(3) cfu/mL) with those for patients with pneumonia due to these pathogens (bacterial counts of > or = 10(3) cfu/mL). Samples were obtained systematically with a protected specimen brush when pneumonia was suspected. Clinical characteristics at admission to our intensive care unit and clinical features at the time of suspicion of VAP were not significantly different between colonized patients and those with VAP. Mortality rates were 29% among colonized patients and 73% among patients with VAP (P < .001). These results demonstrate a relationship between a high mortality rate and the development of pneumonia due to multiresistant, nonfermenting, gram-negative bacilli ( > or = 10(3) cfu/mL) in the lower airways of patients receiving ventilatory support.
Similar articles
- Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D, Clementi E, Gonzalez J, Jusserand D, Asfar P, Perrin D, Fieux F, Aubas S; PneumA Trial Group.Chastre J, et al.JAMA. 2003 Nov 19;290(19):2588-98. doi: 10.1001/jama.290.19.2588.JAMA. 2003.PMID:14625336Clinical Trial.
- Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.Bouglé A, Foucrier A, Dupont H, Montravers P, Ouattara A, Kalfon P, Squara P, Simon T, Amour J; iDIAPASON study group.Bouglé A, et al.Trials. 2017 Jan 23;18(1):37. doi: 10.1186/s13063-017-1780-3.Trials. 2017.PMID:28114979Free PMC article.Clinical Trial.
- Incidence and outcome of polymicrobial ventilator-associated pneumonia.Combes A, Figliolini C, Trouillet JL, Kassis N, Wolff M, Gibert C, Chastre J.Combes A, et al.Chest. 2002 May;121(5):1618-23. doi: 10.1378/chest.121.5.1618.Chest. 2002.PMID:12006452
- Ventilator-associated pneumonia after cardiac surgery: a meta-analysis and systematic review.He S, Chen B, Li W, Yan J, Chen L, Wang X, Xiao Y.He S, et al.J Thorac Cardiovasc Surg. 2014 Dec;148(6):3148-55.e1-5. doi: 10.1016/j.jtcvs.2014.07.107. Epub 2014 Aug 14.J Thorac Cardiovasc Surg. 2014.PMID:25240522Review.
- Ventilator-associated bacterial pneumonia: challenges in diagnosis, treatment, and prevention.Craven DE, Steger KA.Craven DE, et al.New Horiz. 1998 May;6(2 Suppl):S30-45.New Horiz. 1998.PMID:9654310Review.
Cited by
- Genetic diversity of Pseudomonas aeruginosa strains isolated from ventilated patients with nosocomial pneumonia, cancer patients with bacteremia, and environmental water.Ruimy R, Genauzeau E, Barnabe C, Beaulieu A, Tibayrenc M, Andremont A.Ruimy R, et al.Infect Immun. 2001 Jan;69(1):584-8. doi: 10.1128/IAI.69.1.584-588.2001.Infect Immun. 2001.PMID:11119558Free PMC article.
- Imipenem-resistant Acinetobacter baumannii carrying the ISAba1-bla OXA-23,51 and ISAba1-bla ADC-7 genes in Monteria, Colombia.Martínez P, Mattar S.Martínez P, et al.Braz J Microbiol. 2012 Oct;43(4):1274-80. doi: 10.1590/S1517-83822012000400006. Epub 2012 Jun 1.Braz J Microbiol. 2012.PMID:24031953Free PMC article.
- Gold nanoparticle-DNA aptamer-assisted delivery of antimicrobial peptide effectively inhibits Acinetobacter baumannii infection in mice.Park J, Shin E, Yeom JH, Choi Y, Joo M, Lee M, Kim JH, Bae J, Lee K.Park J, et al.J Microbiol. 2022 Jan;60(1):128-136. doi: 10.1007/s12275-022-1620-3. Epub 2021 Dec 29.J Microbiol. 2022.PMID:34964948
- Nosocomial pneumonia : rationalizing the approach to empirical therapy.Andriesse GI, Verhoef J.Andriesse GI, et al.Treat Respir Med. 2006;5(1):11-30. doi: 10.2165/00151829-200605010-00002.Treat Respir Med. 2006.PMID:16409013Free PMC article.Review.
- The protective effects of Ambroxol in Pseudomonas aeruginosa-induced pneumonia in rats.Gao X, Huang Y, Han Y, Bai CX, Wang G.Gao X, et al.Arch Med Sci. 2011 Jun;7(3):405-13. doi: 10.5114/aoms.2011.23403. Epub 2011 Jul 11.Arch Med Sci. 2011.PMID:22312374Free PMC article.
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources